Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune System (Desensitization via Controlled Exposure) (N/A)
- Target
- N/A
- Molecular classification
- N/A - System-level intervention
01
Overview
Desensitization of the immune system through controlled exposure is a therapeutic approach used to reduce or eliminate hypersensitivity reactions (such as allergies) by gradually introducing increasing amounts of an allergen or antigen to the patient. This process aims to retrain the immune system's response, promoting tolerance and reducing pathological reactions upon future exposures. The mechanisms involve early desensitization of mast cells/basophils, intermediate-phase expansion of regulatory T cells, and a late-phase shift in antibody production from IgE to IgG4/IgA.
- Other names
- ImmunotherapyAllergen desensitizationAllergy desensitizationControlled antigen exposure
02
Mechanism of action
Gradual exposure to increasing doses of allergen/antigen leading to mast cell/basophil desensitization, increased regulatory T cell activity, decreased Th2 cell activity, and a shift in antibody production from IgE to IgG4/IgA.
03
Biological functions
Immune modulationTolerance inductionSuppression of hypersensitivityRegulation of immune cell activity
04
Disease associations
AllergiesDrug hypersensitivityAutoimmune disorders (potential)
05
Safety considerations
AnaphylaxisLocal reactions (e.g., swelling, itching)Exacerbation of allergic symptomsNeed for careful dose escalation and monitoring
06
Interacting drugs
Allergens (controlled doses)
3 more in the full profile.
07
Biomarkers
Specific IgE levels (baseline and post-treatment)IgG4 levels (post-treatment)Regulatory T cell populationsMast cell/basophil activation markers
Beyond the preview
Go deeper on Immune System (Desensitization via Controlled Exposure) (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune System (Desensitization via Controlled Exposure) (N/A).